Cargando…

A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis

Background. Sevelamer carbonate is an improved, buffered form of sevelamer hydrochloride developed for the treatment of hyperphosphataemia in CKD patients. Sevelamer carbonate formulated as a powder for oral suspension presents a novel, patient-friendly alternative to tablet phosphate binders. This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Stanley, Ross, Calum, Mitra, Sandip, Kalra, Philip, Heaton, Jeremy, Hunter, John, Plone, Melissa, Pritchard, Nick
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2009
Materias:	Dialysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781155/ https://www.ncbi.nlm.nih.gov/pubmed/19666658 http://dx.doi.org/10.1093/ndt/gfp372

Ejemplares similares

Sevelamer carbonate reduces the risk of hypomagnesemia in hemodialysis-requiring end-stage renal disease patients
por: Rosa-Diez, Guillermo, et al.
Publicado: (2016)

Development and Validation of a Gas Chromatography Method for the Trace Level Determination of Allylamine in Sevelamer Hydrochloride and Sevelamer Carbonate Drug Substances
por: Kadiyala, Raju V. S. N., et al.
Publicado: (2014)

The mortality risk of overhydration in haemodialysis patients
por: Wizemann, Volker, et al.
Publicado: (2009)

Guided optimization of fluid status in haemodialysis patients
por: Machek, Petr, et al.
Publicado: (2010)

Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients
por: Tepel, Martin, et al.
Publicado: (2008)

Vascular calcifications, vertebral fractures and mortality in haemodialysis patients
por: Rodríguez-García, Minerva, et al.
Publicado: (2009)

Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids
por: Gabutti, Luca, et al.
Publicado: (2009)

Correction of metabolic acidosis after conversion from sevelamer hydrochloride to lanthanum carbonate
por: Lindley, Elizabeth, et al.
Publicado: (2008)

Comparison of Turkish and US haemodialysis patient mortality rates: an observational cohort study
por: Asci, Gulay, et al.
Publicado: (2016)

The Home Jail Haemodialysis: a simple way to save money and improve security
por: Cozzolino, Mario, et al.
Publicado: (2019)

Japanese haemodialysis anaemia management practices and outcomes (1999–2006): results from the DOPPS
por: Akizawa, Tadao, et al.
Publicado: (2008)

Integrated care: enhancing transition from renal replacement therapy options to home haemodialysis
por: Slon Roblero, Maria Fernanda, et al.
Publicado: (2019)

Ischemic Colitis in Association with Sevelamer Crystals
por: Keri, K. C., et al.
Publicado: (2019)

Gastrointestinal complications induced by sevelamer crystals
por: Yuste, Claudia, et al.
Publicado: (2017)

Sevelamer Carbonate Crystal-Induced Colitis
por: Lai, T., et al.
Publicado: (2020)

Hard water syndrome: a case series of 30 patients from a London haemodialysis unit
por: Leonard, Hugh, et al.
Publicado: (2019)

Sigmoid colon diverticula perforation associated with sevelamer hydrochloride administration: A case report
por: Yamaguchi, Takahisa, et al.
Publicado: (2016)

Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortality in haemodialysis patients from the AURORA trial
por: Girerd, Sophie, et al.
Publicado: (2019)

Does Sevelamer Hydrochloride (Renagel) Influence 25(Oh)D3 and 1,25(Oh)2D3 Level in Haemodialysis Patients?
por: Strózecki, Pawel, et al.
Publicado: (2005)

Determination of Residual Epichlorohydrin in Sevelamer Hydrochloride by Static Headspace Gas Chromatography with Flame Ionization Detection
por: Karthikeyan, Kaliaperumal, et al.
Publicado: (2010)

Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden
por: Hutchison, Alastair J., et al.
Publicado: (2008)

Sevelamer-Induced Gastrointestinal Injury Presenting as Gastroenteritis
por: Magee, Jared, et al.
Publicado: (2018)

Sevelamer Attenuates Bioprosthetic Heart Valve Calcification
por: Meng, Zhen, et al.
Publicado: (2021)

Binding interactions with sevelamer and polystyrene sulfonate in vitro
por: van Berlo‐van de Laar, Inge R.F., et al.
Publicado: (2021)

Effects of Sevelamer Hydrochloride on Uremic Toxins Serum Indoxyl Sulfate and P-Cresyl Sulfate in Hemodialysis Patients
por: Lin, Cheng-Jui, et al.
Publicado: (2017)

A Retrospective Single-Center Study of Sevelamer Hydrochloride for the Treatment of Hyperphosphatemia in Children With Tumor Lysis Syndrome
por: Al Blewi, Sawsan M, et al.
Publicado: (2023)

A pilot study comparing the efficiency of a novel asymmetric cellulose triacetate (ATA) dialyser membrane (Solacea‐190H) to a standard high flux polysulfone dialyser membrane (FX‐80) in the setting of extended hours haemodialysis
por: Kameshwar, Kamya, et al.
Publicado: (2022)

Molecular Modeling Studies of the Binding Characteristics of Phosphates to Sevelamer Hydrochloride – Assessing a Novel Technique to Reduce Phosphates Contamination
por: Parker, R., et al.
Publicado: (2006)

Endotoxin Binding by Sevelamer: Potential Impact on Nutritional Status
por: Kubotera, Natsuki, et al.
Publicado: (2013)

Colonic Mass Secondary to Sevelamer-Associated Mucosal Injury
por: Bansal, Vishant, et al.
Publicado: (2017)

Sevelamer crystals—an unusual cause of large bowel obstruction
por: Cockrell, Hannah C, et al.
Publicado: (2021)

Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open‐label, multicentre, 12‐week phase III study
por: Koiwa, Fumihiko, et al.
Publicado: (2017)

Different Effect of Lanthanum Carbonate and Sevelamer Hydrochloride on Calcium Balance in Patients with Moderate to Advanced Chronic Kidney Disease
por: Makowka, Agnieszka, et al.
Publicado: (2021)

The Influence of Sevelamer Hydrochloride and Calcium Carbonate on Markers of Inflammation and Oxidative Stress in Hemodialysis at Six Months of Follow-Up
por: Díaz-De la Cruz, Elodia Nataly, et al.
Publicado: (2021)

The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol
por: Pierce, David, et al.
Publicado: (2011)

Update and critical appraisal of sevelamer in the management of chronic renal failure
por: Grinfeld, Jacob, et al.
Publicado: (2010)

A case report of sevelamer-associated recto-sigmoid ulcers
por: Tieu, Christina, et al.
Publicado: (2016)

Comparison of Sevelamer and Calcium Carbonate in Prevention of Hypomagnesemia in Hemodialysis Patients
por: Jandaghi, Elahe, et al.
Publicado: (2021)

Sevelamer carbonate increases serum bicarbonate in pediatric dialysis patients
por: Gonzalez, Elsa, et al.
Publicado: (2010)

Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability
por: de Francisco, Angel L.M., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_hf1pftdd1q3708ju834pgom9qe